Giancarlo Panzica

Prof. Giancarlo Panzica

Univ Turin, Dept Neurosci, Rita Levi Montalcini, I-10126 Turin, Italy
orcid

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Reproductive Toxicology
Verified
Journal Article
Open access
JHJerrold J. Heindel
Jerrold J. Heindel
BBBruce Blumberg
Bruce Blumberg
MCMathew Cave
Mathew Cave
RMRonit Machtinger
Ronit Machtinger
AMAlberto Mantovani
Alberto Mantovani
FSFrederick Vom Saal
Frederick Vom Saal
The recent epidemics of metabolic diseases, obesity, type 2 diabetes(T2D), liver lipid disorders and metabolic syndrome have largely been attributed to genetic background and changes in diet, exercise and aging. However, there is now considerable evidence that other environmental factors may contribute to the rapid increase in the incidence of these metabolic diseases. This review will examine changes to the incidence of obesity, T2D and non-alcoholic fatty liver disease (NAFLD), the contribution of genetics to these disorders and describe the role of the endocrine system in these metabolic disorders. It will then specifically focus on the role of endocrine disrupting chemicals (EDCs) in the etiology of obesity, T2D and NAFLD while finally integrating the information on EDCs on multiple metabolic disorders that could lead to metabolic syndrome. We will specifically examine evidence linking EDC exposures during critical periods of development with metabolic diseases that manifest later in life and across generations.

27 September 2011 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
Cheryl Anne FryeCheryl Anne Frye
Cheryl Anne Frye
EBE. Bo
E. Bo
Gemma CalamandreiGemma Calamandrei
Gemma Calamandrei
LCLaura Calzà
Laura Calzà
FDF. Dessì‐Fulgheri
F. Dessì‐Fulgheri
Giancarlo PanzicaGiancarlo Panzica
Giancarlo Panzica


1 January 1996 in Frontiers in Neuroendocrinology
Verified
Journal Article
Closed access
Giancarlo PanzicaGiancarlo Panzica
Giancarlo Panzica
CVCarla Viglietti-Panzica
Carla Viglietti-Panzica
JBJacques Balthazartb
Jacques Balthazartb
GCGian CarloPanzicaa
Gian CarloPanzicaa

Verified
Journal Article
Open access
PDF file
Maria E StreetMaria E Street
Maria E Street
Sabrina AngeliniSabrina Angelini
Sabrina Angelini
SBSergio Bernasconi
Sergio Bernasconi
EBErnesto Burgio
Ernesto Burgio
ACAlessandra Cassio
Alessandra Cassio
SASergio Amarri
Sergio Amarri
Wildlife has often presented and suggested the effects of endocrine disrupting chemicals (EDCs). Animal studies have given us an important opportunity to understand the mechanisms of action of many chemicals on the endocrine system and on neurodevelopment and behaviour, and to evaluate the effects of doses, time and duration of exposure. Although results are sometimes conflicting because of confounding factors, epidemiological studies in humans suggest effects of EDCs on prenatal growth, thyroid function, glucose metabolism and obesity, puberty, fertility, and on carcinogenesis mainly through epigenetic mechanisms. This manuscript reviews the reports of a multidisciplinary national meeting on this topic.

20 June 2015 in Environmental Health
Verified
Journal Article
Open access
PDF file
JHJerrold J. Heindel
Jerrold J. Heindel
FSFrederick S. Vom Saal
Frederick S. Vom Saal
BBBruce Blumberg
Bruce Blumberg
PBPatrizia Bovolin
Patrizia Bovolin
Gemma CalamandreiGemma Calamandrei
Gemma Calamandrei
Paola PalanzaPaola Palanza
Paola Palanza
A multidisciplinary group of experts gathered in Parma Italy for a workshop hosted by the University of Parma, May 16–18, 2014 to address concerns about the potential relationship between environmental metabolic disrupting chemicals, obesity and related metabolic disorders. The objectives of the workshop were to: 1. Review findings related to the role of environmental chemicals, referred to as “metabolic disruptors”, in obesity and metabolic syndrome with special attention to recent discoveries from animal model and epidemiology studies; 2. Identify conclusions that could be drawn with confidence from existing animal and human data; 3. Develop predictions based on current data; and 4. Identify critical knowledge gaps and areas of uncertainty. The consensus statements are intended to aid in expanding understanding of the role of metabolic disruptors in the obesity and metabolic disease epidemics, to move the field forward by assessing the current state of the science and to identify research needs on the role of environmental chemical exposures in these diseases. We propose broadening the definition of obesogens to that of metabolic disruptors, to encompass chemicals that play a role in altered susceptibility to obesity, diabetes and related metabolic disorders including metabolic syndrome.